Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

4.40
Delayed Data
As of Jun 26
 +0.03 / +0.69%
Today’s Change
2.06
Today|||52-Week Range
5.10
+73.23%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$82.4M

Company Description

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in Hackensack, NJ.

Contact Information

Brainstorm Cell Therapeutics, Inc.
Three University Plaza Drive
Hackensack New Jersey 07601
P:(201) 488-0460
Investor Relations:

Employees

Shareholders

Mutual fund holders4.13%
Other institutional3.86%
Individual stakeholders13.26%

Top Executives

Chaim LebovitsPresident & Chief Executive Officer
Ralph Z. KernChief Operating & Medical Officer
Yoram BibringChief Financial Officer & Treasurer
Yael GothelfVice President-Scientific & Regulatory Affairs
Revital Geffen-ArichaVice President-Research & Development